Local News
27/08/2014
Bayer Vietnam supports children of shrimp farmers in pursuing higher education

Soc Trang Province, 18th August 2014 – Bayer HealthCare Animal Health, Bayer Vietnam today visits and awards children of shrimp farmers in Soc Trang for their excellent performance in the 2014 entrance examinations to universities. Themed “Thanks Parents!”, the program aims to award 250 children in Northern, Central and Southern provinces in 2014, presenting each recipent with a scholarship worth of 500,000 VND (equivalent to US$ 25) and providing the necessities of university life including helmets, backpacks, t-shirts and raincoats.

» more
26/08/2014
Bayer Vietnam held ground breaking ceremony for bridge in remote area of Kien Giang province

Kien Giang province, 23rd August 2014 - More than 1,200 people of An Minh Bac ward, U Minh Thuong district, Kien Giang province celebrated the hard work between People’s Committee of An Minh Bac ward, U Minh Thuong district, Kien Giang province and Bayer Vietnam during a ground breaking ceremony signifying the start of construction for a much-needed bridge named Kenh Xang 2 in the local comunity. The new bridge project is owned by the People’s Committee of An Minh Bac ward, U Minh Thuong district, Kien Giang province while Bayer Vietnam is a donator.

» more
Bayer Global News
Jan 07,2009
Visanne® - new long-term treatment for endometriosis submitted for registration in Europe
Berlin, January 7, 2009 – Bayer Schering Pharma AG, Germany, has submitted Visanne® for the treatment of endometriosis for registration to all Member States of the European Community. The Netherlands will serve as the Reference Member State for the Decentralized Procedure to receive European-wide Marketing Authorization. Visanne contains 2 mg of Dienogest and is administered orally once a day. In contrast to other drugs used for the treatment of this chronic gynecological disease, Visanne is an endometriosis-specific therapy for the long-term treatment of endometriosis. The current standard-therapy with GnRH analogue is only suitable for short-term treatment due to severe side-effects. » more
About Bayer
Working to create value through innovation and growth

Bayer is an international, research-based group with major businesses in health care, nutrition and high-tech materials.

» more
  
Bayer’s Products
Innovation and Growth in Focus

To sharpen our focus on innovation and growth, we have carried out a strategic realignment, placing our businesses into three subgroups that

» more
  
Sustainability and Commitment
Our role as a responsible corporate citizen

Bayer is committed to the concept of sustainable development: with economy

» more
  
Jobs & Career
Our employees and our human resources policy are our key strengths

“We know that the skills, commitment and motivation of our employees are the keys to our corporate success"

» more
  
Search
Publications
Links
Bayer TV
Calendar